Product Information
IBUPROFEN 800 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0585 per EA under NDC 62135040212. Its NADAC has been published 198 times since Nov 9, 2022.
FDA first approved this application on Nov 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Chartwell RX LLCNDC
62135040212
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA202413FDA Approved
11/23/2016
TE Code
AB
On Market Since
11/1/2016
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 800 MG TABLET has been published 198 times since Nov 9, 2022, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0585 per EA |
|---|---|
| All-time high | $0.0747 (Mar 15, 2023) |
| All-time low | $0.0511 (Nov 20, 2024) |
| 52-week high | $0.0601 |
| 52-week low | $0.0549 |
| Median price | $0.0624 |
| Average price | $0.0625 |
| Largest weekly change | -20.3% (Apr 17, 2024) |
| Weeks tracked | 198 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Chartwell RX LLC, is $0.0585 per EA (NDC 62135040212), effective Aug 19, 2026.
How has the price of IBUPROFEN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has declined 20.4%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?
Since Nov 9, 2022, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0511 (Nov 20, 2024) to a high of $0.0747 (Mar 15, 2023), with a median of $0.0624 per EA.
Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 800 MG TABLET, is $0.0567 per EA — about 3% below IBUPROFEN 800 MG TABLET.
Who manufactures IBUPROFEN 800 MG TABLET?
IBUPROFEN 800 MG TABLET (NDC 62135040212) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.